Shell Asset Management Co. lessened its holdings in UnitedHealth Group Inc (NYSE:UNH) by 6.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 100,363 shares of the healthcare conglomerate’s stock after selling 7,323 shares during the period. UnitedHealth Group comprises approximately 0.7% of Shell Asset Management Co.’s portfolio, making the stock its 24th biggest position. Shell Asset Management Co.’s holdings in UnitedHealth Group were worth $25,029,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of UNH. Country Trust Bank boosted its position in shares of UnitedHealth Group by 556.3% in the first quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 89 shares during the period. Tobias Financial Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $29,000. RMR Wealth Builders acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $29,000. HBC Financial Services PLLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Lion Street Advisors LLC acquired a new stake in UnitedHealth Group during the first quarter valued at $31,000. 87.10% of the stock is owned by institutional investors and hedge funds.

In related news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $212.00, for a total transaction of $1,060,000.00. Following the transaction, the director now directly owns 158,598 shares in the company, valued at $33,622,776. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stephen J. Hemsley sold 45,637 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $289.11, for a total value of $13,194,113.07. Following the transaction, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The disclosure for this sale can be found here. Insiders sold 65,637 shares of company stock worth $17,723,013 over the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Shares of UnitedHealth Group stock traded up $1.28 during trading on Friday, reaching $288.19. The company’s stock had a trading volume of 147,368 shares, compared to its average volume of 4,317,679. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.75 and a current ratio of 0.75. The business’s fifty day moving average price is $276.83 and its 200-day moving average price is $276.96. The firm has a market cap of $273.12 billion, a price-to-earnings ratio of 19.98, a price-to-earnings-growth ratio of 1.42 and a beta of 0.72. UnitedHealth Group Inc has a one year low of $187.72 and a one year high of $306.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, topping analysts’ consensus estimates of $3.63 by $0.09. The business had revenue of $64.40 billion for the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a return on equity of 24.86% and a net margin of 5.59%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $3.73 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Inc will post 16.24 EPS for the current year.

A number of analysts recently issued reports on the company. Citigroup reduced their price objective on UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research report on Friday, April 24th. SunTrust Banks lifted their price objective on UnitedHealth Group from $340.00 to $360.00 and gave the company a “buy” rating in a research report on Thursday. Barclays reissued a “buy” rating and set a $322.00 price objective on shares of UnitedHealth Group in a research report on Sunday, March 29th. Morgan Stanley lifted their price objective on UnitedHealth Group from $289.00 to $371.00 and gave the company an “overweight” rating in a research report on Thursday, April 30th. Finally, Credit Suisse Group cut their target price on UnitedHealth Group from $330.00 to $325.00 and set an “outperform” rating on the stock in a report on Thursday, April 16th. Four equities research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $319.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What is insider trading?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.